KRChoksey has come out with its first quarter (April-June’ 21) earnings estimates for the Pharma sector. The brokerage house expects Sun Pharmaceutical Industries to report net profit at Rs 1,346.7 crore up 17.5% year-on-year (down 14.1% quarter-on-quarter).
Net Sales are expected to increase by 12.7 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs 8,547.7 crore, according to KRChoksey.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 4.2 percent Y-o-Y (down 10.8 percent Q-o-Q) to Rs 1,837.8 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More